Cargando…

New Targeted Treatments for Cutaneous T-cell Lymphomas

Cutaneous T-cell lymphomas (CTCLs) represent a group of rare and heterogeneous diseases that are very difficult to treat at advanced stages. The development of monoclonal antibodies is a new hope for the treatment of these diseases. Alemtuzumab (Campath) is a humanized IgG1 kappa monoclonal antibody...

Descripción completa

Detalles Bibliográficos
Autor principal: Bagot, Martine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5363137/
https://www.ncbi.nlm.nih.gov/pubmed/28400633
http://dx.doi.org/10.4103/ijd.IJD_73_17